Chatani F, Nonoyama T, Sudo K, Miyajima H, Takeyama M, Takatsuka D, Mori H, Matsumoto K
Drug Safety Research Laboratories, Takeda Chemical Industries, Ltd., Osaka, Japan.
Anticancer Res. 1990 Mar-Apr;10(2A):337-42.
The development and maintenance of testicular interstitial cell (IC) tumors under the conditions of low LH levels were examined in aged Fischer 344 rats, and the enzyme activities for androgen synthesis in the tumors were estimated. Sixty-week old rats received injections of an LH-RH agonist (LH-RHa) for 28 weeks or were subjected to a procedure by which Silastic tubes containing testosterone (T) or estradiol-17 beta (E) were subcutaneously implanted. All 88-week old control animals had bilateral IC tumors, whereas 100% of the T-, E- and LH-RHa-treated rats at week 88 were tumor free. These treated rats showed significantly reduced peripheral LH levels compared to the control animals. No hyperplasia or tumors of the IC were noted in 70-week old animals receiving T for 28 weeks, while all age-matched untreated animals showed IC tumors or hyperplasia. The IC tumors in rats 69 weeks of age decreased in size in response to 4-week treatment involving the subcutaneous implantation of tubes containing T. After removal of the tubes, however, the tumors once again increased in size. Reduced and subsequently elevated serum LH levels were also observed with this treatment. These changes in tumor mass volume were mainly due to a change in the tumor cell volume which was possibly related to LH levels, i.e., large cells were predominant under relatively high peripheral LH levels and intermediate cells were predominant under low LH levels. Quantitative analyses of the in vitro products formed from [3H]progesterone and [14C]4-androstenedione in tissue-homogenates revealed a low 17 alpha-hydroxylase activity and a high 5 alpha-reductase activity in the IC tumors compared to those activities in the testicular tissues; in the tumors, low production of T and high production of 5 alpha-metabolites of progesterone were observed. From these data, it seems reasonable to conclude that sufficient levels of LH are essential for the induction of IC tumors or hyperplasia and the maintenance of tumor mass, and that the low production of T in the tumors is due, at least in part, to decreased 17 alpha-hydroxylase and increased 5 alpha-reductase activities under active steroidogenesis.
在老年Fischer 344大鼠中研究了低促黄体生成素(LH)水平条件下睾丸间质细胞(IC)肿瘤的发生与维持,并对肿瘤中雄激素合成的酶活性进行了评估。60周龄的大鼠接受促性腺激素释放激素激动剂(LH-RHa)注射28周,或进行皮下植入含睾酮(T)或雌二醇-17β(E)的硅橡胶管的操作。所有88周龄的对照动物均有双侧IC肿瘤,而在第88周时,接受T、E和LH-RHa治疗的大鼠100%无肿瘤。与对照动物相比,这些经治疗的大鼠外周LH水平显著降低。在接受T治疗28周的70周龄动物中,未发现IC增生或肿瘤,而所有年龄匹配的未治疗动物均出现IC肿瘤或增生。69周龄大鼠的IC肿瘤在接受含T的硅橡胶管皮下植入4周的治疗后体积减小。然而,移除硅橡胶管后,肿瘤体积再次增大。这种治疗还观察到血清LH水平先降低后升高。肿瘤质量体积的这些变化主要是由于肿瘤细胞体积的改变,这可能与LH水平有关,即在相对较高的外周LH水平下大细胞占主导,而在低LH水平下中间细胞占主导。对组织匀浆中由[3H]孕酮和[14C]4-雄烯二酮形成的体外产物进行定量分析发现,与睾丸组织相比,IC肿瘤中的17α-羟化酶活性低,5α-还原酶活性高;在肿瘤中,观察到T产量低,孕酮的5α-代谢产物产量高。从这些数据来看,似乎有理由得出结论,足够水平的LH对于IC肿瘤或增生的诱导以及肿瘤质量的维持至关重要,并且肿瘤中T产量低至少部分是由于在活跃的类固醇生成过程中17α-羟化酶活性降低和5α-还原酶活性增加所致。